Clinical Trial Update: The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 results evaluate one-month degarelix dosing regimens in prostate cancer, focusing on efficacy and safety. The trial was sponsored by Ferring Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2009-04-16